J. R. Berenson, H. M. Ma, and R. Vescio, The role of nuclear factor-?b in the biology and treatment of multiple myeloma, Seminars in Oncology, vol.28, issue.6, pp.626-633, 2001.
DOI : 10.1016/S0093-7754(01)90036-3

A. C. Bharti, N. Donato, S. Singh, and B. B. Aggarwal, Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and Ikappa Balpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis, Blood, vol.101, issue.3, pp.1053-1062, 2003.
DOI : 10.1182/blood-2002-05-1320

A. C. Bharti, S. Shishodia, J. M. Reuben, D. Weber, R. Alexanian et al., Nuclear factor-??B and STAT3 are constitutively active in CD138+ cells derived from multiple myeloma patients, and suppression of these transcription factors leads to apoptosis, Blood, vol.103, issue.8, pp.3175-3184, 2004.
DOI : 10.1182/blood-2003-06-2151

A. T. Brenne, T. B. Ro, A. Waage, A. Sundan, M. Borset et al., Interleukin-21 is a growth and survival factor for human myeloma cells, Blood, vol.99, issue.10, pp.3756-3762, 2002.
DOI : 10.1182/blood.V99.10.3756

&. Jove and R. , Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells, Immunity, vol.10, pp.105-115, 1999.

D. Chauhan, H. Uchiyama, Y. Akbarali, M. Urashima, and K. Yamamoto, Libermann, 6-dependent human myeloma cell lines, European Journal of Immunology, vol.27, pp.3332-3340

N. Giuliani, P. Lunghi, F. Morandi, S. Colla, S. Bonomini et al., Downmodulation of ERK protein kinase activity inhibits VEGF secretion by human myeloma cells and myeloma-induced angiogenesis, Leukemia, vol.18, issue.3, pp.628-635, 2004.
DOI : 10.1038/sj.leu.2403269

Z. J. Gu, V. Costes, Z. Y. Lu, X. G. Zhang, V. Pitard et al., Interleukin-10 is a growth factor for human myeloma cells by induction of an oncostatin M autocrine loop, Blood, vol.88, pp.3972-3986, 1996.

Z. J. Gu, J. D. Vos, C. Rebouissou, M. Jourdan, X. G. Zhang et al., Agonist anti-gp130 transducer monoclonal antibodies are human myeloma cell survival and growth factors, Leukemia, vol.14, issue.1, pp.188-197, 2000.
DOI : 10.1038/sj.leu.2401632

T. Hideshima, D. Chauhan, P. Richardson, C. Mitsiades, N. Mitsiades et al., NF-??B as a Therapeutic Target in Multiple Myeloma, Journal of Biological Chemistry, vol.277, issue.19, pp.16639-16647, 2002.
DOI : 10.1074/jbc.M200360200

&. Anderson and K. C. , MLN120B, a novel IkappaB kinase beta inhibitor, blocks multiple myeloma cell growth in vitro and in vivo, Clinical Cancer Research, vol.12, pp.5887-5894, 2006.

J. Moreaux, E. Legouffe, E. Jourdan, P. Quittet, T. Reme et al., BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone, Blood, vol.103, issue.8, pp.3148-3157, 2004.
DOI : 10.1182/blood-2003-06-1984

URL : https://hal.archives-ouvertes.fr/inserm-00129502

H. Ni, M. Ergin, Q. Huang, J. Z. Qin, H. M. Amin et al., Analysis of expression of nuclear factor kappaB (NF-kappaB) in multiple myeloma: downregulation of NF-kappaB induces apoptosis, British Journal of Haematology, vol.44, issue.2, pp.279-286, 2001.
DOI : 10.1006/scbi.1997.0058

E. A. Obeng, L. M. Carlson, D. M. Gutman, W. J. Harrington, . Jr et al., Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells, Blood, vol.107, issue.12, pp.4907-4916, 2006.
DOI : 10.1182/blood-2005-08-3531

C. Rebouissou, J. Wijdenes, P. Autissier, K. Tarte, V. Costes et al., A gp130 interleukin-6 transducerdependent SCID model of human multiple myeloma, Blood, vol.91, pp.4727-4737, 1998.

T. Sanda, S. Iida, H. Ogura, K. Asamitsu, T. Murata et al., Growth inhibition of multiple myeloma cells by a novel IkappaB kinase inhibitor, Clinical Cancer Research, vol.11, 1974.

K. Tarte, X. G. Zhang, E. Legouffe, C. Hertog, M. Mehtali et al., Induced expression of B7-1 on myeloma cells following retroviral gene transfer results in tumor-specific recognition by cytotoxic T cells, Journal of Immunology, vol.163, pp.514-524, 1999.

I. Vermes, C. Haanen, H. Steffens-nakken, and C. Reutelingsperger, A novel assay for apoptosis Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V, Journal of Immunological Methods, vol.184, issue.1, pp.39-51, 1995.
DOI : 10.1016/0022-1759(95)00072-I

P. Viatour, M. P. Merville, V. Bours, and A. Chariot, Phosphorylation of NF-??B and I??B proteins: implications in cancer and inflammation, Trends in Biochemical Sciences, vol.30, issue.1, pp.43-52, 2005.
DOI : 10.1016/j.tibs.2004.11.009

C. Y. Wang, J. C. Cusack, . Jr, R. Liu, A. S. Baldwin et al., Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB, Nature Medicine, vol.5, pp.412-417, 1999.

X. G. Zhang, R. Bataille, J. Widjenes, and B. Klein, Interleukin-6 dependence of advanced malignant plasma cell dyscrasias, Cancer, vol.78, issue.6, pp.1373-1376, 1992.
DOI : 10.1002/1097-0142(19920315)69:6<1373::AID-CNCR2820690612>3.0.CO;2-1

X. G. Zhang, J. P. Gaillard, N. Robillard, Z. Y. Lu, Z. J. Gu et al., Reproducible obtaining of human myeloma cell lines as a model for tumor stem cell study in human multiple myeloma, Blood, vol.83, pp.3654-3663, 1994.